Nanocarriers in skin cancer treatment: Emerging drug delivery approaches and innovations

Abstract

Skin cancer is a growing global health issue, with rising incidence rates, particularly among Caucasian populations. It is the most common malignancy, contributing significantly to mortality and decreased quality of life worldwide. While surgical interventions remain the primary treatment, there is a pressing need for innovative strategies to reduce the morbidity and mortality associated with the disease. As the burden of skin cancer continues to grow, the medical community is increasingly exploring novel therapeutic approaches to improve patient outcomes. Nanotechnology has introduced new possibilities for treating skin cancer, offering advantages in targeted drug delivery, advanced imaging, and diagnostics. Nanomaterials are especially useful in dermatology, as they enhance the penetration and retention of therapeutic agents while minimizing side effects. Various nanomaterials have been studied for their potential in treating skin disorders, including cancer. This review examines the role of nanotechnology in skin cancer treatment, focusing on the development and design of nanocarriers for the precise delivery of drugs. We also discuss the advantages of nanotechnology over traditional treatments, such as improved bioavailability and targeted action. Additionally, we explore clinical trials, patents and FDA approved products related to nanocarrier-based treatments for cancer and skin cancer, highlighting advancements in the field. Nanotechnology holds significant promise in revolutionizing skin cancer treatment. As research progresses, it is expected that more effective, personalized therapies will emerge, ultimately improving patient outcomes. Integrating nanotechnology into clinical practice could elevate the standard of care, offering new hope in managing skin cancer. • Nanotechnology's Role in Skin Cancer Treatment: Nanotechnology offers a promising approach for treating skin cancer by enabling targeted drug delivery, improving drug retention in the skin, and reducing side effects compared to conventional therapies. • Types of Nanomaterials: Various nanomaterials such as liposomes, dendrimers, quantum dots, polymeric nanoparticles, and metallic nanoparticles have been researched for treating skin cancer. These materials enhance drug delivery and diagnostic capabilities. • Advantages Over Traditional Treatments: Nanocarriers improve the pharmacokinetics and pharmacodynamics of anticancer drugs, offering better bioavailability, reduced immunogenicity, and the ability to deliver multiple drugs simultaneously. • Current Clinical Trials: The paper mentions ongoing clinical trials involving nanoparticle-based treatments for skin cancer, highlighting the translational potential of nanotechnology in clinical settings. • Challenges and Future Directions: Despite the potential of nanotechnology, many nano-based treatments are still in the research and development phase. Further studies are needed to optimize safety and efficacy before widespread clinical use.

Topics & Concepts